文献速递妇产影像泌尿生殖US

动态对比增强超声可提高子宫内膜癌分期的诊断效能

Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

这项前瞻性研究纳入101例活检证实的子宫内膜癌患者,比较单独二维经阴道超声/能量多普勒与联合动态对比增强超声诊断深肌层浸润和宫颈间质受累的敏感度和特异度。联合DCE-US提高了深肌层浸润(0.74 vs 0.62,P=0.036)和宫颈间质受累(0.75 vs 0.51,P<0.001)的敏感度,特异度无显著差异;高危癌特异度提高(0.94 vs 0.85,P=0.024),敏感度无差异。

要点

  • 联合DCE-US诊断深肌层浸润敏感度0.74 vs 单独2D-TVU/PD 0.62(P=0.036),特异度无显著差异。
  • 联合DCE-US诊断宫颈间质受累敏感度0.75 vs 单独2D-TVU/PD 0.51(P<0.001),特异度无显著差异。
  • 高危癌特异度联合DCE-US 0.94 vs 单独2D-TVU/PD 0.85(P=0.024),敏感度无差异(0.73 vs 0.71)。

核心结论

  • 与单独2D-TVU/PD相比,联合DCE-US可显著提高子宫内膜癌深肌层浸润和宫颈间质受累的检出,不增加假阳性率;主要通过提高特异度改善高危疾病的正确分类,可能减少近10%不必要的扩大手术。

研究设计与样本

  • 前瞻性研究,纳入101例活检证实的子宫内膜癌连续患者,在Karolinska大学医院(三级转诊中心)由专家行超声检查;所有同意者接受DCE-US(SonoVue 1.5-2.5 mL静脉团注)及常规2D-TVU/PD;研究队列与按FIGO分期和分级3:1匹配的对照队列(仅用2D-TVU/PD,按国际子宫内膜肿瘤分析方案检查)比较;以子宫切除术后病理为金标准。

关键影像表现/征象

  • 高危癌和FIGO分期≥IB的主观DCE-US视频评估特征为「局灶性」充盈模式、「先于」肌层的内膜洗入模式和「局灶性」洗出模式。
  • 半定量DCE-US参数(洗入斜率、达峰时间、峰值强度和时间-强度曲线下面积)均显著预测FIGO分期≥IB,但对高危癌预测未达显著(尽管趋势明显)。

诊断标准与关键数值

  • 深肌层浸润:研究队列联合DCE-US敏感度0.74 vs 对照队列单独2D-TVU/PD 0.62(P=0.036),特异度0.87 vs 0.85(无显著差异)。
  • 宫颈间质受累:研究队列联合DCE-US敏感度0.75 vs 对照队列单独2D-TVU/PD 0.51(P<0.001),特异度0.96 vs 0.95(无显著差异)。
  • 高危癌(定义为FIGO分期≥IB和/或3级子宫内膜样和/或非子宫内膜样组织学):研究队列联合DCE-US特异度0.94 vs 对照队列单独2D-TVU/PD 0.85(P=0.024),敏感度0.73 vs 0.71(无显著差异)。

临床应用与阅片要点

  • 联合DCE-US可在不增加假阳性率的前提下提高深肌层浸润和宫颈间质受累的检出,有助于术前分期。
  • 主观评估中,「局灶性」充盈、「先于」肌层的内膜洗入和「局灶性」洗出模式与更晚期疾病相关,可作为阅片线索。
  • 半定量DCE-US参数对FIGO分期≥IB有显著预测价值,但对高危癌的预测未达统计学显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the sensitivity and specificity of conventional two-dimensional transvaginal ultrasound/power Doppler (2D-TVU/PD) alone and 2D-TVU/PD combined with dynamic contrast-enhanced ultrasound (DCE-US) in diagnosing deep myometrial invasion (MI) and cervical stromal involvement (CSI) in women with endometrial cancer (EC), and to assess the association of DCE-US semiquantitative and qualitative variables with International Federation of Gynecology and Obstetrics (FIGO) Stage ≥ IB and 'high-risk' cancer.

METHODS: This was a prospective study of 101 consecutive women with biopsy-confirmed EC, undergoing expert ultrasound examination at Karolinska University Hospital, a tertiary referral center. All consenting women underwent DCE-US using a 1.5-2.5-mL intravenous bolus of SonoVue contrast agent, as well as conventional 2D-TVU/PD examination. DCE-US videoclips were analyzed with regard to filling (global or focal), wash-in (prior, simultaneous or after) and wash-out (global or focal) patterns of the contrast agent in the tumor compared with the surrounding tissue, as well as semiquantitative DCE-US parameters (wash-in slope, time-to-peak, peak intensity and area under the time-intensity curve (TIC)) obtained from a TIC. The study cohort was compared with a control cohort of women with EC examined at our center according to the International Endometrial Tumor Analysis protocol using 2D-TVU/PD only, matched at a ratio of 3:1 for FIGO stage and grade. The sensitivity and specificity of 2D-TVU/PD alone in the control cohort and in combination with DCE-US in the study cohort in the diagnosis of deep MI, CSI and high-risk cancer (defined as FIGO Stage ≥ IB and/or Grade 3 endometrioid and/or non-endometrioid histology) were compared, using pathological evaluation after hysterectomy as the 'gold standard'.

RESULTS: After exclusions, 93 women were included in the study cohort and were matched to 279 women in the control cohort. The prevalence of FIGO Stage IA, Grade 1-2 EC was 52% in both cohorts. The sensitivity of 2D-TVU/PD with DCE-US in the study cohort was higher than that of 2D-TVU/PD alone in the control cohort in diagnosing both deep MI (0.74 vs 0.62; P = 0.036) and CSI (0.75 vs 0.51; P < 0.001), whereas the specificity was not significantly different (0.87 vs 0.85 and 0.96 vs 0.95, respectively). Compared with 2D-TVU/PD alone, the specificity of 2D-TVU/PD with DCE-US was higher in detecting high-risk cancer (0.94 vs 0.85; P = 0.024) but the sensitivity did not differ (0.73 vs 0.71). High-risk cancer and FIGO Stage ≥ IB were characterized by a 'focal' filling pattern, with a 'prior' wash-in pattern and a 'focal' wash-out pattern on subjective assessment of DCE-US videoclips. All semiquantitative DCE-US parameters were significantly predictive of FIGO Stage ≥ IB but not of high-risk cancer, despite a clear trend.

CONCLUSIONS: Compared with 2D-TVU/PD alone, combining 2D-TVU/PD with DCE-US can significantly improve the detection of deep MI and CSI in women with EC, without increasing the false-positive rate. It can also improve the correct classification of high-risk disease, mainly by increasing specificity, thereby possibly reducing the number of unnecessarily extensive surgeries by almost 10%. Semiquantitative DCE-US parameters, as well as a 'focal' filling pattern, endometrial wash-in prior to the myometrium and a 'focal' wash-out pattern, are all associated with more advanced disease. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Green RW, Epstein E. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging. Ultrasound Obstet Gynecol. 2020. PMID: 31647145. doi:10.1002/uog.21885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。